Cerebral vascular dysfunction causes various ischemic neurological disorders necessitating novel mechanism clarification. In this work, we presented the methods to identify nine single nucleotide polymorphism (SNP) sites of the Pin1 gene in Chinese patients suffered from cerebral infarction for the first time, suggesting that these SNPs have relatively high allele frequencies and may contribute to prevention of Pin1-related neurological diseases. Based on the preliminary interpretations, the SNPs rs2233678 (-842G) and rs2287839 (-5185C) may enhance Pin1 transcription and elicit impacts on thrombosis and atherosclerosis in brain vessels. We further firstly hypothesized a novel Pin1-eNOS-NO-cerebral vasodilatation signaling pathway, which may play a DETRIMENTAL role in cerebrovascular pathologies by blocking vascular diastole/ relaxation and leading to vascular thrombosis/occlusion in the brain. In summary, genetic polymorphisms of Pin1 may represent a new genetic basis for early diagnosis and precision medicine of cerebrovascular dysfunction, and predictably Pin1 inhibitors might have therapeutic efficacy for early prevention of cerebrovascular thrombosis and relevant neural disorders.
Introduction
Some novel neurological studies highlight the pathogenic associations of amyloid-β, tau and genetic polymorphisms with cognitive impairment, Alzheimer's disease (AD), etc. [1] [2] [3] [4] . To our knowledge, the pathogenic mechanisms of cognitive impairment and AD are very complicated. Amongst relevant risk factors, cerebrovascular infarction and microvessel ischemia play very crucial roles in the development of these neurological diseases [5] [6] [7] [8] . Several recent studies tried to explore potential molecular mechanisms underlying cerebral vascular infarction and their relationships with neurological disorders. For example, Raghib et al. found that calcified cerebral emboli result in vascular occlusion and acute stroke in 3 patients, and a simple thrombolysis treatment was not very effective for them [9] . Diacinti et al. described 4 rare cases with cerebral venous thrombosis, which lacks typical vascular signs and is difficult to be diagnosed early [10] . Akpinar et al. reported 8 patients with acute tandem occlusion stroke and performed stentassisted thrombectomy to re-perfuse brain vessels [11] . Rosen et al. investigated the cerebrovascular reactivity of 26 patients with intracranial steno-occlusive disease and evaluated the long-term beneficial effects of extracranial-intracranial bypass on cerebral blood-supply [12] . Moscote-Salazar et al. further analyzed intravenous thrombolysis and recanalization for acute ischemic stroke [13] .
As can be seen, the molecular mechanisms underlying cerebral thrombus and occlusion formation are very complicated, and one major explanation is reduced cerebral vasodilatation, which necessitates further identifying novel molecular basis of vasodilative reduction. In accordance with these ideas, we intend to suggest a potential role of the peptidyl-prolyl cis-trans isomerase Pin1 in these bioactive processes. 
Methods

Patients Description
Blood Preparation, DNA Extraction, PCR Amplification and Gene Sequencing
All reagents for DNA sequencing were provide by the Sangon Biotech, Shanghai. 5 mL peripheral blood was collected, and blood cells were separated by centrifugation (3000 rpm, 10 min, stored at -80℃). DNA was extracted by Ezup Column Blood Genomic DNA Extraction Kit, and then PCR assays were performed. DNA sequences were measured by the 3730XL DNA Analyzer. The PCR primers for nine single nucleotide polymorphism (SNP) sites of Pin1 were shown in our previous studies [14] . 
Results and Discussions
A New Pin1-Based Hypothesis for Cerebrovascular Pathology and Ischemia-Related Neurological Disorders
Pin1 is the only known isomerase that regulates cis-trans structural transition and phosphorylation of many signaling proteins (pThr/pSer-Pro motifs) [18, 19] . Previously, it is well known that amyloid-β deposition and tau aggregation are two major molecular pathologies in cerebral disorders especially AD, but Pin1 regulates processing of amyloid precursor protein and reduces amyloid-β and tau aggregates [19] [20] [21] . In this sense, Pin1 beneficially protects In addition, this work may lay a new genetic basis for future precision medicine. Pin1 gene sequencing may promote precision treatments of cerebrovascular dysfunction and ischemic cerebral diseases, including early diagnosis of high-risk individuals, precision drug development (Pin1 inhibitors), prognostic prediction, with the aim of improving current treatments for the above-mentioned neurological diseases.
